AZ kicks off PhI trial of potential COVID-19 therapy
The monoclonal antibody combination is being tested for prevention and treatment of coronavirus
Read More
Tag: AZD7442
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
